Thrombomodulin Mutations in Atypical Hemolytic–Uremic Syndrome

Mieke Delvaeye; Marina Noris; Astrid De Vriese; Charles T. Esmon; Naomi L. Esmon; Gary Ferrell; Jurgen Del‐Favero; Stéphane Plaisance; Bart Claes; Diether Lambrechts; Carla Zoja; Giuseppe Remuzzi; Edward M. Conway

doi:10.1056/nejmoa0810739

Related publications

Article2009

Atypical Hemolytic–Uremic Syndrome

Marina Noris, Giuseppe Remuzzi

Article2013

Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome

Christophe Legendre, Christoph Licht, Petra Muus, Larry A. Greenbaum, Sunil Babu, Camille L. Bedrosian, Coralie Bingham, D.J. Cohen, Yahsou Delmas, K. Douglas, Frank Eitner, Thorsten Feldkamp, Denis Fouque, Richard R. Furman, Osama Gaber, Maria Herthelius, Maryvonne Hourmant, Diana Karpman, Yvon Lebranchu, Christophe Mariat, Jan Menne, Bruno Moulin, Jens Nürnberger, Masayo Ogawa, Giuseppe Remuzzi, Tristan Richard, Rébecca Sberro‐Soussan, Beth Severino, N. Sheerin, Antonella Trivelli, Lothar Bernd Zimmerhackl, Tim Goodship, Chantal Loirat

Article2013

Thrombomodulin Mutations in Atypical Hemolytic–Uremic Syndrome

Abstract

Discussion(0)

Related publications

Atypical Hemolytic–Uremic Syndrome

Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome

Combined Complement Gene Mutations in Atypical Hemolytic Uremic Syndrome Influence Clinical Phenotype

Liver-Kidney Transplantation to Cure Atypical Hemolytic Uremic Syndrome

Screening for Complement System Abnormalities in Patients with Atypical Hemolytic Uremic Syndrome